Early Dialog

Why is it important?

Obtaining early advice on how to best design your clinical development program in alignment with what payers value ensures that key trial design elements, such as patient populations, endpoints, and comparators, are incorporated in due time to demonstrate the true product value, differentiate it from competitors, and support patient access.

At Creativ-Ceutical, we have an extensive track record

At Creativ-Ceutical, we have prepared 16 early scientific advice requests with HTA as well as 1 EUnetHTA/EMA parallel consultation.